Status:
COMPLETED
Adherence in Adolescents and Children Treated on Quetiapine
Lead Sponsor:
AstraZeneca
Conditions:
Psychosis
Eligibility:
All Genders
7-17 years
Brief Summary
Observational study aimed to describe the adherence in a population of adolescents and children treated on quetiapine from a first psychotic episode whose more important secondary objective is to iden...
Eligibility Criteria
Inclusion
- At least one psychotic symptom (delusions or hallucinations) before age 18.
- Start of treatment in a maximum period of 2 years after the onset of first psychotic symptom
- Written informed consent by parents or guardians and patients.
Exclusion
- Pregnancy or lactancy
- High risk of aggression or suicidal behaviour
- Alcohol dependence
Key Trial Info
Start Date :
August 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00680888
Start Date
August 1 2005
End Date
August 1 2008
Last Update
December 9 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.